Measured effects of user and clinical engineer training using a queuing model

This article puts forward a new proposal to calculate count, turnaround, response, and service time of work orders in a clinical engineering (CE) department. These are calculated by means of a queuing model as a measurement tool. This proposal was tested in a 600-bed hospital with an inventory of 1094 medical devices and with 6 full-time clinical engineers. In April 1999, a simulation (with ARENA 3.01 developed by System Modeling Corporation) of the working of this proposal was performed with desired values being applied to the queuing model. At the end of 2002, real work order data from the database was recorded. As predicted, the results showed that all the indicators of nonscheduled work orders decreased. Response and turnaround time were reduced from 27 to 0.56 hours and 27.48 to 1.13 hours, respectively. From a backlog of 22 outstanding repair orders per month between April 1999 and January 2000, the number was reduced to 4 in December 2002. The queuing model also helped to measure the positive effects on arrival and service rates when users and CE were trained. The difference between simulated and real values was under 5%.     

Identification of proteins of Escherichia coli and Saccharomyces cerevisiae that specifically bind to C/C mismatches in DNA

The pathways leading to G:C→C:G transversions and their repair mechanisms remain uncertain. C/C and G/G mismatches arising during DNA replication are a potential source of G:C→C:G transversions. The Escherichia coli mutHLS mismatch repair pathway efficiently corrects G/G mismatches, whereas C/C mismatches are a poor substrate. Escherichia coli must have a more specific repair pathway to correct C/C mismatches. In this study, we performed gel-shift assays to identify C/C mismatch-binding proteins in cell extracts of E.coli. By testing heteroduplex DNA (34mers) containing C/C mismatches, two specific band shifts were generated in the gels. The band shifts were due to mismatch-specific binding of proteins present in the extracts. Cell extracts of a mutant strain defective in MutM protein did not produce a low-mobility complex. Purified MutM protein bound efficiently to the C/C mismatch-containing heteroduplex to produce the low-mobility complex. The second protein, which produced a high-mobility complex with the C/C mismatches, was purified to homogeneity, and the amino acid sequence revealed that this protein was the FabA protein of E.coli. The high-mobility complex was not formed in cell extracts of a fabA mutant. From these results it is possible that MutM and FabA proteins are components of repair pathways for C/C mismatches in E.coli. Furthermore, we found that Saccharomyces cerevisiae OGG1 protein, a functional homolog of E.coli MutM protein, could specifically bind to the C/C mismatches in DNA.     

Control problems and management policies in health systems: application to intensive care units

The stochastic nature of both patient arrivals and lengths of stay leads inevitably to periodic bed shortages in healthcare units. Physicians are challenged to fit demand to service capacity. If all beds are occupied eligible patients are usually referred to another ward or hospital and scheduled surgeries may be cancelled. Lack of beds may also have consequences for patients, who may be discharged in advance when the number of occupied beds is so high as to compromise the medical care of new incoming patients. In this paper we deal with the problem of obtaining efficient bed-management policies. We introduce a queuing control problem in which neither the arrival rates nor the number of servers can be modified. Bed occupancy control is addressed by modifying the service time rates, to make them dependent on the state of the system. The objective functions are two quality-of-service components: to minimize patient rejections and to minimize the length of stay shortening. The first objective has a clear mathematical formulation: minimize the probability of rejecting a patient. The second objective admits several formulations. Four different expressions, all leading to nonlinear optimization problems, are proposed. The solutions of these optimization problems define different control policies. We obtain the analytical solutions by adopting Markov-type assumptions and comparing them in terms of the two quality-of-service components. We extend these results to the general case using optimization with simulation, and propose a way to simulate general length of stay distributions enabling the inclusion of state-dependent service rates.     

Impact of Interleukin-18 Polymorphisms -607A/C and -137G/C on Oral Cancer Occurrence and Clinical Progression

Background

The purpose of this study was to identify gene polymorphisms of interleukin-18 (IL-18) -607A/C and -137G/C specific to patients with oral cancer susceptibility and clinicopathological status.

Methodology and Principal Findings

A total of 1,126 participants, including 559 healthy people and 567 patients with oral cancer, were recruited for this study. Allelic discrimination of -607A/C (rs1946518) and -137G/C (rs187238) polymorphisms of the IL-18 gene was assessed by a real-time PCR with the TaqMan assay. There was no significant association between IL-18 -607A/C polymorphism and oral cancer risk. However, among alcohol consumers, people with A/A homozygotes of IL-18 -607A/C polymorphism had a 2.38-fold (95% CI=1.17-4.86; p=0.01) increased risk of developing oral cancer compared with those with C/C homozygotes. The participants with G/C heterozygotes of IL-18 -137 polymorphism had a 1.64-fold (95% CI: 1.08-2.48; p=0.02) increased risk of developing oral cancer compared with those with G/G wild type homozygotes. Both sets of statistics were determined after adjusting for confounding factors. Among people who had exposure to oral cancer-related environmental risk factors such as areca, alcohol, and tobacco consumption, the adjusted odd ratios and 95% confidence intervals were increased to a 2.02-fold (95% CI=1.01-4.04; p=0.04), 4.04 (95% CI=1.65-9.87; p=0.002) and a 1.66-fold (95% CI=1.00-2.84; p=0.05) risk of developing oral cancer. However, patients with G/C alleles of IL-18 -137 were correlated with a lower clinical stage (AOR=0.59; 95% CI=0.39-0.89; p=0.01), smaller tumor size (AOR=0.56; 95% CI=0.35-0.87; p=0.01), and non-lymph node metastasis (AOR=0.51; 95% CI=0.32-0.80; p=0.003).

Conclusion

IL-18 -137 G/C gene polymorphism may be a factor that increases the susceptibility to oral cancer, as well as a protective factor for oral cancer progression. The interactions of gene to oral cancer-related environmental risk factors have a synergetic effect that can further enhance oral cancer development.     

Mononuclear and dinuclear iridium and heterodinuclear iridium-rhodium complexes derived from 1,4-C6H4(CCSiMe3)2 as precursor

The labile iridium(I) precursor trans-[IrCl(C₈H₁₄)(PiPr₃)₂] (2), prepared in situ from [IrCl(C₈H₁₄)₂]₂ (1) and PiPr₃, reacted with equimolar amounts of 1,4-C₆H₄(CCSiMe₃)₂ (3) at 60 °C to give the mononuclear vinylidene complex trans-[IrCl(CC(SiMe₃)C₆H₄CCSiMe₃)(PiPr₃)₂] (4). From 2 and 3 in the molar ratio of 2:1, the dinuclear compound trans,trans-[(PiPr₃)₂ClIr(CC(SiMe₃)C₆H₄C(SiMe₃)C)IrCl(PiPr₃)₂] (5) was obtained. Reaction of 4 with [RhCl(PiPr₃)₂]₂ (6) at room temperature afforded the heterodinuclear alkyne(vinylidene) complex trans,trans-[(PiPr₃)₂ClIr(CC(SiMe₃)C₆H₄CCSiMe₃)RhCl(PiPr₃)₂] (7), which on heating at 45 °C was converted to the bis(vinylidene) isomer trans,trans-[(PiPr₃)₂ClIr(CC(SiMe₃)C₆H₄C(SiMe₃)C)RhCl(PiPr₃)₂] (8).     

Cooperativity of Cdk4R24C and Ras in melanoma development

The importance of the Cdk4 protein in human cancer became evident following the identification of a germ line mutation in the Cdk4 locus that predisposes humans to melanoma. This mutation results in substitution of argininefirst with cysteine at position 24 (R24C). In an earlier study, we introduced the R24C mutation into the Cdk4 locus of mice using Cre-loxp-mediated “knock-in” technology and observed a very low incidence of spontaneous melanomas in Cdk4^R24C/R24C mice. This suggested that additional oncogenic mutations might be required for development of melanomas. Here we report an increased incidence of spontaneous cutaneous melanoma in mice expressing the oncogene HRAS(G12V) in melanocytes on a Cdk4^R24C background. Treatment of Tyr-HRas:Cdk4^R24C/R24C mice with the carcinogen, DMBA/TPA resulted in a further increase in the number of nevi and melanomas developed when compared with Tyr-HRas:Cdk4^+/+ mice. In summary, in Tyr-HRas:Cdk4^R24C/R24C mice, we observed that activated Cdk4 cooperates with the oncogenic HRAS(G12V) protein to increase the susceptibility of melanoma development in vivo.Key words: Cdk4^R24C, ras, melanoma, skin, carcinogen     

Maximum Entropy Principle Based Estimation of Performance Distribution in Queueing Theory

In related research on queuing systems, in order to determine the system state, there is a widespread practice to assume that the system is stable and that distributions of the customer arrival ratio and service ratio are known information. In this study, the queuing system is looked at as a black box without any assumptions on the distribution of the arrival and service ratios and only keeping the assumption on the stability of the queuing system. By applying the principle of maximum entropy, the performance distribution of queuing systems is derived from some easily accessible indexes, such as the capacity of the system, the mean number of customers in the system, and the mean utilization of the servers. Some special cases are modeled and their performance distributions are derived. Using the chi-square goodness of fit test, the accuracy and generality for practical purposes of the principle of maximum entropy approach is demonstrated.     

Photosynthetic/Photorespiratory Carbon Metabolism in the C(3)-C(4) Intermediate Species, Moricandia arvensis and Panicum milioides

The distribution of ¹⁴C in photosynthetic metabolites of two naturally occurring higher plants with reduced photorespiration, Moricandia arvensis and Panicum milioides, in pulse and pulse-chase ¹⁴CO₂ incorporation experiments was similar to that for the C₃ species, M. foetida and Glycine max. After 6 seconds of ¹⁴CO₂ incorporation, only about 6% of the total ¹⁴C fixed was in malate and aspartate in both M. arvensis and P. milioides. The apparent turnover of the C₄ acids was very slow, and malate accumulated during the day in M. arvensis. Thus, C₄ acid metabolism by M. arvensis and P. milioides had no significant role in photosynthetic carbon assimilation under the conditions of our experiments (310 microliters CO₂ per liter, 21% O₂, 1100 or 1900 micromoles photon per square meter per second, 27°C).

After a 36-second chase period in air containing 270 microliters CO₂ per liter, about 20% of the total ¹⁴C fixed was in glycine with M. arvensis, as compared to 15% with M. foetida, 14% with P. milioides, and 9% with G. max. After a 36-second chase period in 100 microliters CO₂ per liter, the percentage in glycine was about twice that at 270 microliters CO₂ per liter in the C₃ species and P. milioides, but only 20% more ¹⁴C was in glycine in M. arvensis. These data suggest that either the photorespiratory glycine pool in M. arvensis is larger than in the other species examined or the apparent turnover rate of glycine and the flow of carbon into glycine during photorespiration are less in M. arvensis. An unusual glycine metabolism in M. arvensis may be linked to the mechanism of photorespiratory reduction in this crucifer.

     

Lamin A/C mutations alter differentiation potential of mesenchymal stem cells

Mutations in the lamin A/C gene (LMNA) lead to severe disorders collectively called laminopathies. The mechanisms by which lamin mutations cause the diseases are not clear. Since the mesenchymal lineages, adipose tissue in particular, are mostly affected in laminopathies, the aim of the study was to estimate the effect of LMNA mutations on differentiation of mesenchymal stem cells, adipose tissue stromal cells (ATSCs), into adipose lineages. ATSCs transduced with lentiviral vectors carrying LMNA gene mutations associated with various syndromes (myodystrophy, cardiomyopathy, lipodystrophy, progeroid syndrome) were induced to adipose differentiate. It was found that introduction of genetic constructions with LMNA gene point mutations G465D, R482L, and R527C promote adipogenic differentiation compared to wild-type lamin gene; mutation R471C reduced the differentiation. Introduction of R471C or R527C lamin mutations profoundly increased the expression of adipogenesis markers PPARG, SREBP1, and adipsin. Mutations in A/C lamin gene strongly and variously affect the differentiation of mesenchymal stem cells that probably underlie the pathogenic changes in patients with laminopathies.     

Orthomercurated and cycloaurated derivatives of the iminophosphorane Ph3PNPh

Ortho-lithiation of Ph₃PNPh followed by reaction with HgCl₂ gave good yields of [Hg{C₆H₄(PPh₂NPh)-2}Cl], 3, which was characterised spectroscopically and by an X-ray crystal structure determination. This is an isomer of the product of direct mercuration of Ph₃PNPh which occurs on the N-bonded phenyl ring [J. Vicente, J.A. Abad, R. Clemente, J. Lopez-Serrano, M.C. Ramirez de Arellano, P.G. Jones, D. Bautista, Organometallics, 22 (2003) 4248]. Transmetallation of 3 with [AuCl₄]⁻ gave the corresponding cycloaurated complex [Au{κ²-C,N-C₆H₄(PPh₂NPh)-2}Cl₂], with a five-membered metallocyclic ring incorporating four different elements.     

Direct quantification of M/G ratio from C CP-MAS NMR spectra of alginate powders by multivariate curve resolution

Multivariate curve resolution (MCR) was applied to ¹³C cross-polarisation (CP) magic angle spinning (MAS) nuclear magnetic resonance (NMR) spectra of non-depolymerised alginate powders obtained from brown seaweed plus a pure mannuronate sample isolated from Pseudomonas fluorescens for estimation of the mannuronic acid/guluronic acid ratio (M/G ratio). An excellent MCR model with a correlation coefficient of r² = 0.99 was established between the estimated M/G ratios and the M/G ratios obtained from the traditional ¹H solution state NMR method. The new method allows for successful determination of the M/G ratio independent of the calcium content (at least up to 2.4%, which was the upper limit in this study) with a root mean square error of prediction of 0.05. It is thus concluded that ¹³C CP-MAS NMR in combination with multivariate curve resolution is a reliable, convenient (no sample preparation is required) and relatively rapid method for M/G ratio determinations of alginates and it may serve as a good alternative to the chemical techniques traditionally used.     

Oncogenic KRAS G12C: Kinetic and redox characterization of covalent inhibition

The recent development of mutant-selective inhibitors for the oncogenic KRAS^G12C allele has generated considerable excitement. These inhibitors covalently engage the mutant C12 thiol located within the phosphoryl binding loop of RAS, locking the KRAS^G12C protein in an inactive state. While clinical trials of these inhibitors have been promising, mechanistic questions regarding the reactivity of this thiol remain. Here, we show by NMR and an independent biochemical assay that the pK_a of the C12 thiol is depressed (pK_a ∼7.6), consistent with susceptibility to chemical ligation. Using a validated fluorescent KRAS^Y137W variant amenable to stopped-flow spectroscopy, we characterized the kinetics of KRAS^G12C fluorescence changes upon addition of ARS-853 or AMG 510, noting that at low temperatures, ARS-853 addition elicited both a rapid first phase of fluorescence change (attributed to binding, K_d = 36.0 ± 0.7 μM) and a second, slower pH-dependent phase, taken to represent covalent ligation. Consistent with the lower pK_a of the C12 thiol, we found that reversible and irreversible oxidation of KRAS^G12C occurred readily both in vitro and in the cellular environment, preventing the covalent binding of ARS-853. Moreover, we found that oxidation of the KRAS^G12C Cys12 to a sulfinate altered RAS conformation and dynamics to be more similar to KRAS^G12D in comparison to the unmodified protein, as assessed by molecular dynamics simulations. Taken together, these findings provide insight for future KRAS^G12C drug discovery efforts, and identify the occurrence of G12C oxidation with currently unknown biological ramifications.     

Crystal and molecular structures of {Cu(μ-CCPh)(triphos)}2 [triphos = (PPh2CH2)3CMe]

The binuclear complex {Cu(μ-CCPh)(triphos)}₂ [triphos = (PPh₂CH₂)₃CMe] has been obtained from a reaction between {Cu(CCPh)}_n and triphos. The two copper atoms are bridged unsymmetrically by two CCPh groups, each attached through one carbon only [Cu-C, 2.016(4) Å], the separation between the two coppers being 2.4663(8) Å. Only two of the three phosphorus atoms in each ligand are coordinated to copper [Cu-P(1,2) 2.281, 2.273(1) Å]. The observed structure may be rationalised using a recent theoretical study [C. Mealli, S.S.M.C. Godinho, M.J. Calhorda, Organometallics 20 (2001) 1734] and differs from that assumed for the rationalisation of its luminescence properties [V. Pawlowski, G. Knör, C. Lennartz, A. Vogler, Eur. J. Inorg. Chem. (2005) 3167].     

Characterization of the three major polymorphic forms and liquid state of tristearin by Raman spectroscopy

Raman spectroscopy was used to distinguish the differences in the molecular organization of the α, β′ and β polymorphs, as well as the liquid state, of tristearin with focus placed on the CO, CH and CC Raman-active stretching regions. The ester carbonyl stretching region permitted polymorphic discrimination due to significant differences in the number of modes, their relative frequencies and their full-widths at half-maximum. In the liquid state, the absence of obvious signatures in this region indicated that many local micro-environments likely exist about the ester carbonyl of molten tristearin. The ratio between the symmetrical and asymmetrical CH stretching modes was linearly correlated with the enthalpy of fusion for each polymorph. The CC stretching modes, which provided insight into the trans/gauche content, were polymorph independent, but changed significantly upon transition into the liquid state (p < 0.05). Overall, Raman spectroscopy allowed for the quick discrimination of tristearin polymorphs from a conformational and thermodynamic perspective.     

Facile synthesis of 2-aryl 5-hydroxy benzo[d]oxazoles and their in vitro anti-proliferative effects on various cancer cell lines

2-Aryl 5-hydroxy benzo[d]oxazoles were designed as potential anticancer agents. A one-pot synthesis of these compounds dispenses the need for ortho-disubstituted precursor, aminophenol and proceeds via CN formation as a key step followed by CO cyclization to form benzo[d]oxazoles. The single crystal X-ray diffraction study was used to confirm the molecular structure of a representative compound unambiguously. All of these compounds were evaluated for their anti-proliferative properties in vitro against five cancer cell lines as well as noncancerous cells. Most of these compounds showed selective growth inhibition of cancer cells and few of them were found to be promising with IC₅₀ values in the range of 0.8–2.8?μM, comparable to the known anticancer drug doxorubicin.     

Rapid,highly sensitive method for the determination of morphine and its metabolites in body fluids by liquid chromatography–mass spectrometry

A rapid, highly sensitive method for the determination of morphine and its metabolites morphine-3-glucuronide (M3G), morphine-6-glucuronide (M6G) and normorphine has been developed using high-performance liquid chromatography–electrospray mass spectrometry, with the deuterated analogues as internal standards. The analytes were extracted automatically using end-capped C₂ solid-phase extraction cartridges. Baseline separation of morphine, M3G and M6G was achieved on a LiChrospher 100 RP-18 end-capped analytical column (125×3 mm I.D., 5 μm particle size) with water–acetonitrile–tetrahydrofuran–formic acid (100:1:1:0.1, v/v) as the mobile phase. Morphine and normorphine coeluate and were separated mass spectrometrically. The mass spectrometer was operated in the selected-ion monitoring mode using m/z 272 for normorphine, m/z 286 for morphine, m/z 462 for morphine-6-glucuronide. Due to an interfering peak, M3G was measured by tandem mass spectrometry in the daughter-ion mode. The limits of quantitation achieved with this method were 1.3 pmol/ml for morphine, 1.5 pmol/ml for normorphine, 1.0 pmol/ml for M6G and 5.4 pmol/ml for M3G in serum or cerebrospinal fluid. The limits of quantitation achieved in urine were 10 pmol/ml for morphine, 20 pmol/ml for normorphine and M6G and 50 pmol/ml for M3G using a sample size of 100 μl. The method described was successfully applied to the determination of morphine and its metabolites in human serum, cerebrospinal fluid and urine in pharmacokinetic and drug interaction studies.     

Development of a gradient elution high-performance liquid chromatography assay with ultraviolet detection for the determination in plasma of the anticancer peptide [Arg6, d-Trp7,9, mePhe8]-substance P (6–11) (antagonist G), its major metabolites and a C-terminal pyrene-labelled conjugate

[Arg⁶, d-Trp^7,9, mePhe⁸]-substance P (6–11), code-named antagonist G, is a novel peptide currently undergoing early clinical trials as an anticancer drug. A sensitive, high efficiency high-performance liquid chromatography (HPLC) method is described for the determination in human plasma of antagonist G and its three major metabolites, deamidated-G (M1), G-minus Met¹¹ (M2) and G[Met¹¹(O)] (M3). Gradient elution was employed using 40 mM ammonium acetate in 0.15% trifluoroacetic acid as buffer A and acetonitrile as solvent B, with a linear gradient increasing from 30 to 100% B over 15 min, together with a microbore analytical column (μBondapak C₁₈, 30 cm×2 mm I.D.). Detection was by UV at 280 nm and the column was maintained at 40°C. Retention times varied by <1% throughout the day and were as follows: G, 13.0 min; M1, 12.2 min; M2, 11.2 min; M3, 10.8 min, and 18.1 min for a pyrene conjugate of G (G–P). The limit of detection on column (LOD) was 2.5 ng for antagonist G, M1–3 and G–P and the limit of quantitation (LOQ) was 20 ng/ml for G and 100 ng/ml for M1–3. Sample clean-up by solid-phase extraction using C₂-bonded 40 μm silica particles (Bond Elut, 1 ml reservoirs) resulted in elimination of interference from plasma constituents. Within-day and between-day precision and accuracy over a broad range of concentrations (100 ng/ml–100 μg/ml) normally varied by <10%, although at the highest concentrations of M1 and M2 studied (50 μg/ml), increased variability and reduced recovery were observed. The new assay will aid in the clinical development of antagonist G.     

Mononuclear and tetranuclear palladacycles with terdentate [C,N,N] and [C,N,O] Schiff base ligands. C-H versus C-Br activation reactions

Reaction of the Schiff base ligands 2-Br-4,5-(OCH₂O)C₆H₂C(H)NCH₂CH₂NMe₂ (a) and 4,5-(OCH₂CH₂)C₆H₃C(H)NCH₂CH₂NMe₂ (b) with Pd(OAc)₂ or K₂[PdCl₄] leads to the mononuclear cyclometallated compounds [Pd{2-Br-4,5-(OCH₂O)C₆HC(H)NCH₂CH₂NMe₂-C6,N,N}(OCOMe)] (1a) and [Pd{4,5-(OCH₂CH₂)C₆H₂C(H)NCH₂CH₂NMe₂-C6,N,N}(Cl)] (1b), derived from C-H activation at the C6 carbon. Treatment of a with Pd₂(dba)₃ gave [Pd{4-5-(OCH₂O)C₆H₂C(H)NCH₂CH₂NMe₂-C2,N,N}(Br)] (2a), via C-Br activation.The metathesis reaction of 1a with aqueous sodium chloride gave [Pd{2-Br-4,5-(OCH₂O)C₆HC(H)NCH₂CH₂NMe₂-C6,N,N}(Cl)] (3a), with exchange of the acetate group by a chloride ligand. Treatment of the cyclometallated monomers 1a-3a with PPh₃ in a 1:1 molar ratio yielded the mononuclear complexes [Pd{2-Br-4,5-(OCH₂O)C₆HC(H)NCH₂CH₂NMe₂-C6,N}(L)(PPh₃)] (L: OAc, 4a; Cl, 5a) and [Pd{4-5-(OCH₂O)C₆H₂C(H)NCH₂CH₂NMe₂-C2,N}(Br)(PPh₃)] (6a), with Pd-NMe₂ bond cleavage. However, treatment of a solution of 3a or 2a with silver trifluoromethanesulfonate, followed by reaction with PPh₃ in acetone yielded the cyclometallated complexes [Pd{2-Br-4,5-(OCH₂O)C₆HC(H)NCH₂CH₂NMe₂-C6,N,N}(PPh₃)][CF₃SO₃] (7a) and [Pd{4-5-(OCH₂O)C₆H₂C(H)NCH₂CH₂NMe₂-C2,N,N}(PPh₃)][CF₃SO₃] (8a), respectively, where the Pd-NMe₂ bond was retained.The reaction of the ligands 2-Br-4,5-(OCH₂O)C₆H₂C(H)N(2′-OH-5′-^tBuC₆H₃) (c) and 4,5-(OCH₂CH₂)C₆H₃C(H)N(2′-OH-5′-^tBuC₆H₃) (d) with Pd(OAc)₂ gave the tetranuclear complexes [Pd{2-Br-4,5-(OCH₂O)C₆HC(H)N(2′-O-5′-^tBuC₆H₃)-C6,N,O}]₄ (1c) and [Pd{4,5-(OCH₂CH₂)C₆H₂C(H)N(2′-O-5′-^tBuC₆H₃)-C6,N,O}]₄ (1d), respectively. Treatment of 1c with PPh₃ in 1:4 molar ratio, gave the mononuclear species [Pd{2-Br-4,5-(OCH₂O)C₆HC(H)N(2′-(O)-5′-^tBuC₆H₃)-C6,N,O}(PPh₃)] (2c) with opening of the polynuclear structure after P-O_bridging bond cleavage.The structure of compounds 2a, 1c and 1d has been determined by X-ray diffraction analysis.     

Synthesis and characterization of some oxovanadium(V) complexes with internally functionalized oximes: Crystal and molecular structures of heptacoordinated [VO{ONC(CH3)(C4H3O-2)}3] and [VO{ONC(CH3)(C4H3S-2)}3] · 0.5C6H6

New oxovanadium(V) complexes with internally functionalized oximes of the type VO{OPrⁱ}_3−n{ONC(CH₃)(Ar)}_n] (where Ar = C₄H₃O-2, C₄H₃S-2 and C₅H₄N-2 and n = 1-3) have been prepared in quantitative yields by the reaction of VO(OPrⁱ)₃ with the corresponding oximes in various stoichiometric ratios in refluxing anhydrous benzene. The products have been characterized by elemental analyses and spectroscopic (FT IR, ¹H, ¹³C{¹H} and ⁵¹V NMR) studies. FAB mass spectral analysis of [VO{OPrⁱ}{ONC(CH₃)C₄H₃S}₂] indicates the monomeric nature of the complex. ⁵¹V NMR values for these complexes suggest the formation of tetra-coordinate species in solution. However, the single crystal X-ray diffraction studies of [VO{ONC(CH₃)(C₄H₃O-2)}₃] and [VO{ONC(CH₃)(C₄H₃S-2)}₃] · 0.5C₆H₆ exhibit the presence of vanadium(V) atoms in a unique hepta-coordination state with distorted pentagonal bipyramidal geometry in the solid state. The oxo- atom occupies the axial position while the oximato ligands are bonded in a dihapto (η²-N,O) manner with the formation of three membered rings.